Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 374

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 374
---
 a cumulative basis. For Swiss resident individuals as well as non -Swissresident individual taxpayers holding NLS Common Shares or Preferred Shares as part of a trade or business carried on in Switzerland, the Merger should be tax neutral for the purposes of Swiss federal, cantonal and communal tax, provided that the relevant tax book value of the shares is maintained. Otherwise, a taxable gain or tax deductible loss for the purposes of Swiss federal, cantonal and communal income tax may arise. For Swiss resident corporate taxpayers as well as non -Swissresident corporate taxpayers holding the NLS Common Shares or Preferred Shares as part of a trade or business carried on in Switzerland, the Merger should be tax neutral for the purposes of Swiss federal, cantonal and communal tax, provided that the tax relevant book value of the shares is maintained. Otherwise, a taxable gain or tax deductible loss for the purposes of Swiss federal, cantonal and communal income tax may arise. Non -Swissresidents who are holding NLS Common Shares and Preferred Shares and who are not resident do not hold them as part of a trade or business carried on in Switzerland for Swiss tax purposes are not subject to any Swiss federal, cantonal or communal income tax. Therefore, the Merger has no tax implications on such holders of NLS Common Shares or Preferred Shares. 207 Swiss Stamp Duty and Swiss Securities Transfer Tax For stamp duty purposes (Emissionsabgabe), an exemption has been applied. In consequence, the Merger is not subject to Swiss stamp. Therefore, a tax ruling has been filed with the Swiss Federal Tax Administration. The Merger is further not subject to Swiss securities transfer tax (Umsatzabgabe). General Swiss Tax Considerations Taxation of NLS Pharmaceutics Ltd. NLS is a Swiss based company, subject to unlimited taxation in the Canton of Zurich. NLS is taxed at a statutory corporate income tax rate of approximately 18.9% (including direct federal as well as cantonal/communal taxes). In addition, an annual capital tax rate of approximately 0.16% is levied on the net equity of NLS. Swiss Withholding Tax on Dividends and other Distributions Dividend payments and similar cash or in -kinddistributions on the NLS Common Shares or Preferred Shares (including dividends on liquidation proceeds and share dividends) that NLS makes to shareholders are subject to Swiss withholding tax (Verrechnungssteuer) at a rate of 35% on the gross amount of the dividend. NLS is